The Gcn5p histone acetyltransferase exhibits a limited substrate specificity in vitro. However, neither the specificity of this enzyme in vivo nor the importance of particular acetylated residues to transcription or cell growth are well defined. To probe these questions, we mutated specific lysines in the N-termini of histones H3 and H4 and examined the effects of these mutations in yeast strains with and without functional GCN5. We found that in vivo, GCN5 is required either directly or indirectly for the acetylation of several sites in H3 and H4 in addition to those recognized by the recombinant enzyme in vitro. Moreover, in the absence of GCN5, cells accumulate in G 2 /M indicating that Gcn5p functions are important for normal cell-cycle progression. Mutation of K14 in H3, which serves as the major target of recombinant Gcn5p acetylation in vitro, confers a strong, synthetic growth defect in gcn5 cells. Synergistic growth defects were also observed in gcn5 cells carrying mutations in lysine pairs (K8/K16 or K5/K12) in histone H4. Strikingly, simultaneous mutation of K14 in H3 and K8 and K16 in H4 to arginine, or deletion of either the H3 or the H4 N-terminal tail, results in the death of gcn5 cells. Mutation of these same three sites to glutamine is not lethal. Indeed, this combination of mutations largely bypasses the need for GCN5 for transcriptional activation by Gal4-VP16, supporting an important role for histone acetylation in Gcn5p-mediated regulation of transcription. Our data indicate that acetylation of particular lysines in histones H3 and H4 serves both unique and overlapping functions important for normal cell growth, and that a critical overall level of histone acetylation is essential for cell viability.
Introduction
The packaging of eukaryotic DNA into chromatin influences every process that utilizes DNA as a template, including transcription, recombination, replication and repair. The nucleosome core particle serves as the basic repeat unit of chromatin and comprises an octamer of the four core histones with~146 bp DNA wound around the outside (van Holde, 1989) . Nucleosomes are folded together into higher order structures, and both individual nucleosomes and more highly folded forms of chromatin limit the access of trans-acting factors to DNA, thereby inhibiting transcription and other processes .
Histones contain a central, globular domain which is important for histone-histone interactions and nucleosome formation (van Holde, 1989) . In addition, relatively unstructured and highly charged N-terminal tail domains extrude from the histone octamer, and these tails are important for DNA-histone interactions within and between nucleosomes, as well as for nucleosome-nucleosome interactions (Hansen, 1997) . In addition, these N-terminal domains function in histone deposition and nucleosome assembly during S phase, in transcriptional regulation, and in the maintenance of genome integrity (Megee et al., 1995; Turner, 1995; Roth and Allis, 1996; Ura et al., 1997) . Post-translational acetylation of lysine residues within these N-terminal tails facilitates binding of transcriptional activators to nucleosomal DNA (Lee et al., 1993) , at least in part through neutralization of the positive charge associated with the lysine ε-amino group (Turner, 1991; Wolffe and Pruss, 1996) . Acetylation also affects higher order packing of chromatin (Fletcher and Hansen, 1996) and interactions of non-histone proteins with the histones .
Recent discoveries that indicate several transcriptional activators or co-activators possess histone acetyltransferase activity provide a molecular basis for a long-standing correlation between histone acetylation and transcriptional activation (Wade et al., 1997) . Yeast Gcn5p and its Tetrahymena homolog were the first of this class of proteins to be identified as catalytic subunits of histone acetyltransferase type A (HAT A) activities . Gcn5p is part of larger complexes that contain Ada2p, Ada3p, Ada5p and/or other proteins (Marcus et al., 1994 (Marcus et al., , 1996 Horiuchi et al., 1995; Candau and Berger, 1996; Roth and Allis, 1996; Grant et al., 1997; Roberts and Winston, 1997) . The Gcn5p-Adap complex was initially described as a transcriptional adaptor, based on the finding that it is needed by several acidic transactivators for the activation of transcription (Berger et al., 1992) , and the ability of components of the complex to interact with both these transactivators and basal transcription proteins such as TBP Barlev et al., 1995) . Interactions between the acetyltransferase complex and DNA-binding transactivators suggest a mechanism by which these enzymes might be directed to specific regions of the genome for transcriptional activation. Moreover, mutations in GCN5 that eliminate Gcn5p acetyltransferase activity in vitro are defective in transcriptional activation in vivo Wang et al., 1997) , further indicating that histone acetylation is required for Gcn5p-mediated activation events.
Recombinant Gcn5p (rGcn5p) displays a non-random specificity for acetylation of lysines in the N-termini of histones H3 and H4 (Kuo et al., 1996) . The N-termini of these two histones are remarkably conserved across species, and each contains multiple conserved lysines that serve as sites of post-translational acetylation (Turner, 1991) . In H4, acetylation occurs on lysines (K) 5, 8, 12 and 16. Acetylation of K5 and K12 is linked to histone deposition into newly synthesized chromatin during S phase in several species (Sobel et al., 1995) , and acetylation of K16 is commonly enriched in transcriptionally active and potentially active chromatin (Turner, 1993; Roth and Allis, 1996; Johnson et al., 1998) . Acetylation of histone H3 occurs at lysines 9, 14, 18 and 23. Acetylation of K9 is correlated with histone deposition, whereas acetylation of the other sites may be associated with transcription (Kuo et al., 1996; Roth and Allis, 1996) . Accordingly, mutation of multiple sites in H3 and/or H4 in yeast confers specific transcriptional and cell growth defects (Grunstein, 1990; Smith, 1991; Roth, 1995) . Recombinant Gcn5p preferentially acetylates K14 of H3 in vitro and K8 and K16 of H4 (Kuo et al., 1996; Roth and Allis, 1996) .
GCN5 is not an essential gene in yeast, which suggests either the existence of other acetyltransferase activities with overlapping (and redundant) specificities or that acetylation of lysines other than those recognized by Gcn5p can generate histones that are functionally equivalent to those acetylated at Gcn5p target sites. To address these questions and to examine the importance of specific acetylation events to cell growth and transcriptional activation in vivo, we mutated lysines previously identified as rGcn5p substrate or non-substrate sites in H3 and/or H4 in yeast cells containing or lacking GCN5. Our data suggest that acetylation of particular lysines in H3 and H4 likely serves both redundant and unique functions, and that in vivo Gcn5p is required for acetylation of sites in H3 and H4 that are not recognized by the recombinant enzyme in vitro. Moreover, our findings indicate that GCN5 is required for normal progression of the cell cycle and that a crucial balance of histone acetylation at specific lysines is essential for cell viability.
Results

Synthetic growth defects induced by H3 K14 mutations in gcn5 cells
To test the importance of acetylation at specific sites in H3 and H4 in vivo, we engineered a set of isogenic GCN5 or gcn5 yeast strains in which the endogenous H3 and H4 loci (HHT1-HHF1 and HHT2-HHF2) are disrupted and in which these histones are provided by a plasmid-borne copy of HHT2-HHF2. Specific mutated versions of these histone genes were then introduced by a plasmid shuffle protocol (Materials and methods). We initially focused on the mutation of H3 since this histone is the primary in vitro target of both rGcn5p (Kuo et al., 1996) and native Gcn5p-containing complexes isolated from yeast (Grant et al., 1997) . In particular, we mutated the major substrate site for rGcn5p in H3, lysine 14 (K14) to arginine or to glutamine. For comparison, we also mutated lysine 9 (K9), Fig. 1 . Growth of cells bearing acetylation site mutations on 3-ATcontaining media. GCN5 or gcn5 cells (as indicated) containing wildtype or mutated versions of H3 or H4 were grown on minimal media containing 3-AT. Under these conditions gcn5 cells grow more slowly than GCN5 cells, although this plate was allowed to grow to a point where this difference is not obvious in order to illustrate the more extreme growth defects of gcn5 cells bearing particular mutations in H3 or H4. a site we previously reported to be not recognized by rGcn5p (Kuo et al., 1996;  Figure 1 ). We reasoned that if a major purpose of acetylation is the neutralization of charge on lysine side chains, conversion of K14 to neutral amino acids such as glutamine (Q) might mimic acetylation and bypass the need for GCN5, whereas conversion of K14 to arginine (R) might enhance defects associated with GCN5 loss. Alternatively, if the change in charge is not the primary role of acetylation, then these mutations might confer similar phenotypes, reflecting changes in structure.
It has been reported previously that growth of gcn5 cells was inhibited on media containing 3-aminotriazole (3-AT) due to inefficient activation of genes involved in histidine biosynthesis. Therefore, we first compared growth of GCN5 or gcn5 cells containing specific histone mutations on this media ( Figure 1 ). As expected, in the presence of wild-type histones gcn5 cells grew noticeably more slowly than GCN5 cells on 3-AT-containing media. Even in rich media, gcn5 cells exhibited a lengthened doubling time (172 min) relative to wild-type cells (104 min; Figure 2 ). Interestingly, this lengthened doubling time is associated with a moderately increased proportion of cells in G 2 , and a decreased proportion of cells in G 1 (Figure 3) .
Conversion of K14 in H3 to glutamine (Q), arginine (R) or glycine (G) had only modest effects on the doubling time of GCN5 cells (Figures 1 and 2 ), indicating that permanent fixation of a positive or neutral charge at this site does not abrogate essential H3 functions. In contrast, gcn5 cells bearing these mutations exhibited markedly increased doubling times (Figure 2) . In rich media, the doubling time of these cells was extended from 172 min (wild-type H3) to 264 (H3 K14→Q) or 275 min (H3 K14→R). A depletion of cells in G 1 is observed in both the GCN5 and gcn5 cell populations, with an increased number of cells in G 2 (Figure 3) . These results are similar to previously observed delays in progression through G 2 /M for cells bearing several different mutations in the N-termini of histones H3 or H4 (Megee et al., 1990 (Megee et al., , 1995 Durrin et al., 1991; Morgan et al., 1991) . Importantly, the common phenotype for all three of the K14 H3 (Q, R and G) mutations indicates that the loss of the lysine residue is the most significant change and that the change in charge may be less important than the change in structure of this residue upon acetylation. Moreover, the synergistic growth defects we observe when GCN5 null mutations are combined with these H3 mutations suggest redundancies both in functions of specific acetylation events and in the enzymes that mediate these events.
GCN5 is required for acetylation of H3 K9 and H3 K18 in vivo
In contrast to the K14 mutations above, mutation of K9 in H3 did not exhibit a synergistic effect on doubling time of gcn5 cells. Cells lacking GCN5 and bearing K9→Q or K9→R mutations divide in rich media every 184 or 188 min, respectively (Figure 2 ), similar to the doubling time of the gcn5 cells carrying wild-type H3. Both mutations show an increased number of cells with a 2N content of DNA (data not shown).
To further investigate possible connections between acetylation at specific sites and Gcn5p function, we examined the acetylation states of wild-type or various mutant forms of H3 established in vivo, in the presence or absence of GCN5. Histones were isolated from cells bearing these mutations and probed with H3-specific antibodies (Figure 4 ). One antiserum, αH3, recognizes both acetylated and unacetylated forms of H3 (data not shown). Two other antisera, αH3 Ac K9,14 (generously provided by D.Allis, University of Rochester) and αH3Ac K9,18 recognize specific acetylated forms of H3 (data not shown).
The wild-type, K14→R and K9→R forms of H3 all reacted equally well with the αH3 antiserum, regardless of whether they were isolated from GCN5 or gcn5 cells ( Figure 4B and D) . As expected, deletion of the H3 tail (Δ3-29; Figure 4B , lane 6) abolishes the reaction with this antibody. Interestingly, the K14→R form of H3 isolated from GCN5 cells reacted strongly with the αH3 Ac K9,14 antiserum ( Figure 4C , lane 3). Since the H3 K14→R mutation inevitably eliminates acetylation at K14, the high degree of reactivity with the αH3 Ac K9,14 antibody indicates that this histone is well acetylated at K9. Consistent with these observations, the K9→R version of H3 (isolated from GCN5 cells) reacted very poorly with the αH3 Ac K9,14 antiserum ( Figure 4C , lane 5). Since K14 is still available for acetylation in this mutant, the reduced reactivity with this antibody could reflect a bias in the specificity of the antibody towards K9 or a predominance of K9 acetylation (over K14) in bulk populations of wild-type histones. It is also possible that mutation at K9 might decrease acetylation at K14, resulting in decreased antibody recognition. In any case, this antibody clearly reacts well with H3 acetylated at K9. Interestingly, both the wild-type and the K14→R forms of H3 exhibited reduced reactivity with this antiserum when isolated from gcn5 cells ( Figure 4C , compare lanes 2 and 4 with lanes 1 and 3). These data indicate that GCN5 is required for full acetylation of K9 in H3 in vivo.
To determine whether GCN5 is also required for acetylation of K18 in H3 in vivo, wild-type or K9→R mutant forms of H3 were probed with the αH3 Ac K9,18 antiserum. When isolated from GCN5 cells, both wildtype and K9→R H3 reacted well with this antiserum ( Figure 4E , lanes 1 and 3) indicating either that this antibody has a predominant reactivity towards K18 or that the steady-state level of K18 acetylation is higher than that of K9 in the total population of H3 molecules. In either case, a much reduced activity of this antiserum towards wild-type and the K9→R forms of H3 was observed when these histones were isolated from gcn5 cells ( Figure 4E , lanes 2 and 4), indicating that acetylation of K18 is also at least partially dependent on GCN5 in vivo.
To determine whether the requirement of Gcn5p for these acetylation events is direct or indirect, we next examined the ability of rGcn5p to acetylate forms of H3 bearing mutations at K9 or K14 (isolated from GCN5 cells) in vitro. If rGcn5p normally acetylates these sites, then each mutation should decrease the level of acetylation achieved. As expected, rGcn5p acetylated wild-type H3 very efficiently ( Figure 5B , lane 1). Also as expected, mutation of K14 to Q or R largely abolished this acetylation ( Figure 5B , compare lanes 3 and 6 with 1). In contrast, mutation of K9 had minimal effects ( Figure 5B , compare lanes 9 and 12 with 1). The decreased acetylation of the K14 mutant form of H3 is not due to an inhibitor present in our histone preparations, since mixtures of the mutant and wild-type histones were acetylated quite well by rGcn5p ( Figure 5B , lanes 5 and 8). These results confirm our previous findings that K14 is a key target for rGcn5p acetylation in vitro (Kuo et al., 1996) .
If K9 is largely acetylated in vivo as indicated by our experiments, then this residue would not be available in our isolated histones, or in histones used in previous studies (Kuo et al., 1996) , for in vitro acetylation by rGcn5p. To further analyze the ability of Gcn5p to acetylate K9, K14 or K18 in vitro, we utilized a set of peptides as substrates that correspond to amino acids 5-28 in H3 ( Figure 5C ). Acetyllysine was substituted for lysine at various positions during synthesis of these peptides to generate specific acetylated states. As expected, rGcn5p efficiently acetylated the H3 peptide that contained no acetyllysine groups but was unable to use as substrate a peptide containing four acetyllysine moieties at positions 9, 14, 18 and 23 ( Figure 5C , 'Tetra'). The remaining peptides each contained three acetyllysine groups at different positions, leaving a single site available for in vitro acetylation in each. Only the peptide in which K14 was available was acetylated efficiently by rGcn5p. All peptides containing acetyllysine at position 14, including peptides in which K9 or K18 were left open, served as very poor substrates for rGcn5p. These data confirm that K14 is the predominant site of acetylation in H3 by rGcn5p in vitro. In vivo, native Gcn5p-Adap or SAGA complexes (Grant et al., 1997) might exhibit an expanded substrate specificity, including K9 and K18 in H3. Alternatively, Gcn5p might influence acetylation of these sites indirectly.
Redundant functions of H4 acetylation for cell growth
Several studies have examined the function of the four highly conserved lysines (K5, K8, K12 and K16) in the H4 N-terminus in yeast, and mutations in one or more of these sites directly affect cell growth (Megee et al., 1990 (Megee et al., , 1995 Durrin et al., 1991; Morgan et al., 1991) . Interestingly, simultaneous mutation of all four sites to glutamine leads to a decreased proportion of cells in G 1 with an increased number of cells in G 2 (Megee et al., 1995) . This cell-cycle defect is rescued by the addition of a single lysine, independent of the site of insertion in the H4 N-terminus. These experiments suggest that lysines indicates that a mixture of wild-type and mutant histones (as indicated for each set) were utilized as substrate. Following the reaction, histones were displayed by SDS-PAGE (A), and 3 H acetate-labeled histones were detected by autoradiography (B). (C) Synthetic peptides containing acetyl lysine moieties at various combinations of sites in H3 were tested as substrates for rGcn5p in the presence of 3 H-acetyl CoA. Shown are TCA precipitable counts incorporated into each peptide. 'Un' indicates the peptide substrate was synthesized without any acetyllysine groups and was unacetylated prior to reaction with rGcn5p. 'Tetra' indicates the peptide was synthesized with acetyllysine moieties at each of the four positions normally acetylated in vivo in H3, as indicated. All other peptides were synthesized with acetyllysine at each of these positions except for the one indicated under the bar, such that the indicated lysine is the only site available for acetylation in that peptide. located at multiple positions in H4 can provide overlapping or redundant functions needed for normal cell growth. To further link the functions of these residues to their acetylation state, we examined the effects of mutations in K8 and K16 or in K5 and K12 in cells containing or lacking GCN5.
Conversion of the previously identified Gcn5p target sites in H4, K8 and K16, to Q or to R slowed growth in the presence of GCN5, as predicted by previous findings (Megee et al., 1990 (Megee et al., , 1995 Durrin et al., 1991; Morgan et al., 1991; Figure 6 ). In both GCN5 and gcn5 cells containing the K8/16 H4 mutations, an increased proportion of cells with a G 2 content of DNA was observed (Figure 3 ; data not shown). Interestingly, combination of the K8/K16→Q H4 mutations with loss of GCN5 did not relieve or exacerbate the gcn5 slow growth phenotype on 3-AT-containing media (Figure 1 ) or on rich media ( Figure  6 ), but conversion of these residues to R significantly enhanced the gcn5 slow growth phenotype (Figure 6 ), resulting in a doubling time of 239 min.
Strikingly, mutation of the two other acetylation sites in H4, K5 and K12, also induced an extreme slow growth phenotype in the absence of GCN5 (257 min for K5/12→Q and 273 min for K5/12→R; Figure 6 ) and accumulation of cells in G 2 /M (data not shown). In this case, both R and Q mutations exhibited very similar effects on cell growth, indicating that the loss of acetylatable lysines at these positions has ramifications beyond the alteration in charge.
Since previous studies indicated that rGcn5p acetylates only K8 and K16 in H4, we were surprised to observe a significant amount of acetylation of the K8/16→R or Q forms of H4 by rGcn5p in vitro ( Figure 5B , compare labelling of H4 in lanes 3 and 6 with that in 1, 9 and 12). These data suggest that, under some conditions, K5 and/or K12 might be acetylated by rGcn5p. To investigate the possibility that the acetylation states of K5 and K12 in H4 might also be influenced in vivo by GCN5, we probed wild-type and mutant forms of this histone with antibodies specific for particular acetylation states (Turner et al., 1992) . We first probed H4 isolated from GCN5 or gcn5 cells with an antibody raised against a non-acetylated H4 peptide that recognizes non-, mono-and diacetylated forms of H4 (B.Turner, unpublished observations) but does not recognize more highly acetylated forms of this histone ( Figure 7B ). H4 isolated from GCN5 cells exhibited slightly lower reactivity with this antibody compared with H4 isolated from gcn5 cells, suggesting that H4 is more highly acetylated when GCN5 is present. Consistent with this, we found that loss of GCN5 caused a diminution of acetylation at each of the four acetylation sites in H4 ( Figure 7C-F) , as determined by a lowered reactivity with antibodies specific for acetylation at each individual site. Changes in acetylation levels at multiple sites in H4 provide an explanation for the synergistic effects in cell growth that we observe upon concomitant GCN5 loss and mutation of either the K5/12 or the K8/16 lysine pairs. Furthermore, our data also support a redundancy in at least some functions of acetylation at these four sites.
Essential functions of acetylation revealed by concomitant mutation of H3 and H4 in gcn5 cells
The possibility of redundant functions for acetylation of particular sites in H3 versus H4 was tested by examining the effects of combined mutations in these histones in GCN5 or gcn5 cells.
Combination of H3 K14→Q and H4 K8/K16→Q mutations had relatively minimal effects on cell growth in the presence of GCN5 (136 min doubling time; Figure  8 ), indicating that this combination of mutations does not overtly interfere with H3 and H4 functions. In gcn5 cells, however, this combination of mutations results in a severe 3160 growth defect (351 min doubling time; Figure 8 ), significantly worse than the individual H3 or H4 mutations described above. Severe defects in cell growth were also observed in gcn5 cells bearing mutations at other sites (K9 in H3 and K5/12 in H4), but in this case the defect is more similar to that seen with cells bearing the H4 K5/12 mutation alone (Figures 6 and 8 ). An increased proportion of cells in G 2 was observed in the presence of all of these combined mutations, in both GCN5 and gcn5 cells (Figure 3; data not shown) .
Strikingly, combination of the H3 K14→R and H4 K8/K16→R mutations in gcn5 cells is lethal. We were repeatedly unable to complete a plasmid shuffle protocol to introduce these histone alleles into gcn5 cells. In these experiments, both a URA3-marked plasmid bearing wildtype histones H3 and H4 and a TRP1-marked plasmid bearing the mutated H3 and H4 genes were introduced into cells disrupted for the endogenous H3 and H4 genes. After growth in Ura ϩ media, cells that had lost the URA3-marked, wild-type histone plasmid were selected on 5-FOA-containing media. Although we typically obtained thousands of 5-FOA-resistant colonies from GCN5 cells, very few were recovered from gcn5 cells (Table I) , and these were subsequently determined (by Southern analysis; data not shown) to have undergone rearrangement events such that they no longer contained the mutant histone alleles. We were also unable to recover this combination of mutated H3, H4 and gcn5 alleles from sporulation of diploid cells heterozygous for both the mutant histones and GCN5, although all other expected combinations of alleles were observed at the expected frequency (Ͼ30 tetrads dissected; data not shown). This synthetic lethality is limited to particular target sites of rGcn5p, since we successfully recovered gcn5 colonies bearing combined H3 K9→R and H4 K5/12→R mutations after plasmid shuffle (Table I; Figure 8 ). Interestingly, we find that deletion of the N-terminal tail of either H3 (residues 3-29) or H4 (residues 4-19) in gcn5 cells is also lethal (Table I ; unpublished sporulation analysis), indicating that a critical level of histone acetylation must be maintained for cell viability.
Nucleosome assembly in GCN5 or gcn5 cells is not grossly changed by mutation of either Gcn5p-target or deposition-related acetylation sites The effects of specific lysine mutations on cell growth in rich media in the absence of gcn5 could reflect either defective organization of chromatin or defective regulation of transcription, or both. To determine whether these mutations affect chromatin organization at the level of nucleosome assembly, we examined the superhelical density of the endogenous 2μ plasmid in these various strains. Each nucleosome imparts one negative supercoil to a circular plasmid, so comparison of plasmid topoisomer distributions provides an estimate of the relative number of nucleosomes assembled onto the plasmid in vivo.
We focused on strains containing combined H3 and H4 mutations, since these exhibited the most severe growth defects ( Figure 9 ). No gross changes in superhelical density of the 2μ plasmid were observed in any of these strains (Figure 9 ). Other strains bearing single H3 or double H4 mutations in isolation were also examined, but again, no gross changes in topoisomer distribution were observed (data not shown). At most, a change in linking number corresponding to a change of one to two nucleosomes per plasmid was observed in gcn5 cells carrying the combined K14→Q H3, K8/16→Q H4 alleles relative to GCN5 cells bearing these same mutations. In this case, however, the increased topoisomer density would indicate that the plasmid actually carries an increased number of nucleosomes in these gcn5 cells. Interestingly, even simultaneous mutation of all deposition-related lysines in H3 (K9) and H4 (K5/12) to R (Figure 9 ) did not cause a gross loss of nucleosomes from the plasmid, comparable, for example, with that observed by others upon simultaneous loss of both the H3 and H4 N-terminal tails (Ling et al., 1996) . Our results indicate that acetylation of these lysines is not required absolutely for histone deposition and nucleosome assembly in vivo, although certainly acetylation may facilitate these processes.
Mutation of target lysines affects transcriptional activation by GCN5
GCN5 is required for transcriptional activation by several acidic transactivator proteins in yeast, including heterologous VP16 derivatives (Berger et al., 1992; Marcus et al., 1994) . A truncated form of VP16 (residues 413-470) fused to the Gal4p DNA binding domain (GAL4-VP16 413-470 ) strongly activates a reporter construct bearing a Gal4p binding site in wild-type cells (Barlev et al., 1995) . Only 2 units of activity are observed in the absence of GAL4-VP16 413-470 (data not shown) whereas Ͼ600 units are observed in wild-type cells in the presence of the activator ( Figure 10A ). As expected,~9-fold less activation of the reporter by GAL4-VP16 413-470 is observed in the absence of GCN5 ( Figure 10A ). Previous studies have demonstrated that Gal4p-VP16 expression is not changed in gcn5 cells (Berger et al., 1992) , and we find that the copy number of the reporter construct is also unchanged in these cells or in the cells harboring the various histone mutations described below (data not shown). Decreases in reporter expression, therefore, reflect ineffective activation by Gal4p-VP16.
The K14→Q mutation in H3 does not suppress the Fig. 9 . Nucleosome density on the endogenous 2μ plasmid in GCN5 or gcn5 cells is not grossly affected by acetylation site mutations in H3 and/or H4. The distribution of 2μ plasmid topoisomers in extracts from the indicated strains was examined after chloroquin gel electrophoresis, as described in Materials and methods. The mean topoisomer distribution is not grossly changed in the various strains, indicating a similar density of nucleosomes present on the plasmid in these cells. All samples were resolved in the same gel, but a darker exposure of the fourth lane is presented to facilitate comparisons.
gcn5 transcriptional phenotype but does cause a 2-fold hyperactivation of the reporter in GCN5 cells ( Figure  10A ). Conversion of K14 to R decreases reporter expression slightly in GCN5 cells but does not exacerbate the transcriptional defect in the absence of GCN5. Conversion of K14 to G (data not shown) or mutation of K9 to either Q or R increases reporter expression 2-to 3-fold in both GCN5 and gcn5 cells. Interestingly, increased activation of other genes, including the natural GAL1 promoter, in the presence of other H3 N-terminal mutations has been observed previously (Mann and Grunstein, 1992) . Similarly, mutation of lysine pairs (K5/12 or K8/16) in H4 to Q or R neither suppresses nor enhances the need for GCN5 for transcriptional activation of the reporter gene by GAL4-VP16 413-470 ( Figure 10B ). In all cases, 6-to 10-fold lower levels of expression are observed in gcn5 cells relative to GCN5 cells, although the absolute levels of activation were increased in both types of cells in the presence of the various H4 mutations ( Figure 10B ).
Although the separate conversion of K14 in H3 or K8/ K16 in H4 to Q did not suppress the requirement for GCN5 in transcriptional activation by VP16 , simultaneous conversion of these three GCN5 substrate sites to Q largely bypassed the need for GCN5 for activation of the reporter gene ( Figure 10C) . Indeed, the level of activation in the gcn5 cells reached 68% of that achieved in the GCN5 cells. These data support an important role for acetylation of specific lysines in H3 and H4 for Gcn5p-mediated activation of transcription.
Discussion
The recent identification of a bevy of regulatory proteins as histone acetyltransferases and deacetylases implies clear connections between this histone modification, gene expression and cell growth. However, since some acetyltransferases recognize both non-histone and histone substrates (Gu and Roeder, 1997; Imhof et al., 1997) , the importance of histone acetylation relative to acetylation of other targets has come into question. We directly tested the importance of histone acetylation to cell growth and transcription by combining mutations in substrate lysines in histones H3 and H4 with null alleles of the GCN5 acetyltransferase in yeast. Our data indicate that GCN5 is required for full levels of acetylation at multiple sites in H3 and H4 in vivo. These acetylation events are important for normal progression of the cell cycle and for transcriptional activation. Moreover, our data demonstrate that a critical overall level of acetylation is essential for cell viability.
Acetylation neutralizes the positive charge associated with the ε-amino group of lysine moieties and therefore weakens interactions with the negatively charged DNA. If charge neutralization is a primary purpose of acetylation by Gcn5p, mutation of substrate lysines in H3 and H4 to the neutral amino acid glutamine or to the charged amino acid arginine might suppress or enhance, respectively, the requirement for Gcn5p for transcriptional activation or for normal cell growth. However, in all but one case (involving concomitant conversion of K14 in H3 and K8/16 in H4), the Q and R mutations we examined elicited very similar effects upon cell growth and transcription. Our results indicate that loss of the acetylatable lysines has consequences beyond changes in charge, likely reflecting alterations in structure of the tail domains (Hansen, 1997) or in the association of non-histone, regulatory proteins with these domains . Acetylation also likely increases the mobility of the tail domains (Cary et al., 1982; Hong et al., 1993; Ura et al., 1997) , and our mutations may restrict such mobility.
Redundant and essential functions of GCN5
Multiple acetyltransferase activities have been identified previously in yeast extracts (Travis et al., 1984; Grant et al., 1997) . In addition, other specific acetyltransferases have been identified, including yeast TAF130 (Mizzen et al., 1996) . The synthetic growth defects we observed upon mutation of target sites and loss of GCN5 predict that at least some of these other activities will have substrate specificities overlapping with, but not identical to, those of Gcn5p. Indeed, acetyltransferase complexes with a predominant specificity for H4, rather than the preference of H3 exhibited by Gcn5p, have been isolated from yeast extracts (Grant et al., 1997) . Such additional acetyltransferase activities that acetylate wild-type H3 and/or H4 in gcn5 cells could minimize the effects of GCN5 loss, but when these histones are mutated such that they are no longer substrates for any of these enzymes, more serious defects in cell growth should ensue, as we observed.
The synthetic growth defects and the synthetic lethality that occurs in gcn5 cells carrying certain histone mutations also indicate that Gcn5p affects acetylation of additional targets in H3, H4 or other proteins in vivo that are not recognized by the recombinant protein in vitro. Consistent with this, we find that full acetylation of multiple lysines in H3 and H4 is dependent on GCN5 in vivo. In principle, this might reflect an interdependence of acetylation events, i.e. acetylation of one lysine might be required prior to acetylation of another. However, examination of the acetylation states of single site substitution mutants in H4 indicates that all four sites in this histone are acetylated independently (H.Johnson, Ph.D. thesis, University of Birmingham). Our data suggesting additional targets for Gcn5p in vivo complement recent findings by Grant et al. (1997) that indicate complexes isolated from yeast containing Gcn5p/Ada2p also acetylate histone H2B. Thus, Gcn5p can acetylate at least three of the four core histones 3163 in vitro and this enzyme influences acetylation of multiple sites within at least two of these histones in vivo.
Our finding that concomitant mutation of the three lysines recognized by recombinant Gcn5p in vitro, K14 in H3 and K8, K16 in H4, to glutamine can largely bypass the need for Gcn5p in activation of transcription by Gal4-Vp16 in vivo clearly supports an important role for the acetylation of these residues in Gcn5p-mediated activation events. Since GCN5 is required for full acetylation of K9 in H3 and of all four sites in H4, it is possible that other combinations of mutations might have similar effects. However, conversion of K9 in H3 and K5, K12 in H4 to glutamine did not bypass the need for GCN5 for Gal4-VP16 activation, and conversion of these sites to arginine was not synthetically lethal with the GCN5 null allele. Therefore, acetylation events at these various sites in H3 and H4 have at least some unique functions in transcriptional regulation and cell growth. In future experiments, it will be interesting to examine other combinations of mutations, for example K9→Q in H3 with K8, K16→Q in H4 or K14→Q in H3 with K5, K12→Q in H4, for their effects on these processes.
Roles for Gcn5p-mediated acetylation in cell growth
The defective progression of gcn5 cells (containing wildtype histones) through G 2 /M may be due to defective transcription of genes needed for cell-cycle advancement, or it may indicate that Gcn5p-mediated acetylation is important for changes in chromatin structure that occur during G 2 in preparation for mitosis, or both. Our results are consistent with previous studies (Morgan et al., 1991; Megee et al., 1995) that indicate the N-termini of H3 and H4 are required for normal cell-cycle progression and that the H4 N-terminus plays a role in maintenance of genome integrity. Our data now link these processes more directly to acetylation of these histones. Future studies will examine possible connections between H3 and H4 acetylation and particular cell cycle or DNA damage checkpoints.
Cells bearing GCN5 disruptions are temperature sensitive for growth at 37°C, and this lethality is not rescued by any of the H3 or H4 mutations we examined (W.Zhang, unpublished observations). Our finding that deletion of GCN5 is lethal even at the permissive temperature of 30°C when combined with a truncation of either the H3 or the H4 N-terminus is reminiscent of findings by Ma et al. (1996) . These researchers uncovered a set of hsl (histone synthetic lethal) mutations, all of which also exhibited lethality in combination with N-terminal deletions in H3 or H4. Interestingly, two of the HSL genes, HSL1 and HSL7, and a dosage-dependent suppressor of hsl1 and hsl7 mutations, OSS1, are all regulators of the Swe1p kinase, an important cell-cycle regulator. Like GCN5, HSL1 and HSL7 are not essential genes, but cells lacking these genes exhibit a defect in progression through G 2 /M. These similarities may simply reflect the involvement of the H3 and H4 tail domains in multiple processes affecting cell-cycle progression, but they also suggest the intriguing possibility that GCN5 functions, particularly histone acetylation, might be directly linked to cell-cycle controls via Swe1p or the HSL genes. MATa, trp1Δ63, his3Δ200, leu2Δ1, but MATα WZY42 as DY881, GCN5/ gcn5::URA3, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, leu2Δ1/leu2Δ1, WZY193 as WZY192, Materials and methods
Yeast culture
Saccharomyces cerevisiae strains were propagated according to standard procedures in either rich media (YPD) or appropriate selective media (SC or SD) as needed. In some experiments, cells were also cultured in the presence of 10-100 mM 3-AT (100 mM in plate depicted in Figure  1 ). Strains used in this study are listed in Table II . All are isogenic to DY881 and DY882 (generously provided by D.Stillman, University of Utah) and are derived from S288C. Yeast were transformed according to Hill et al. (1991) . To measure doubling times, cells were diluted into YPD and counted at defined intervals during exponential growth.
Disruption of HHT1-HHF1 and HHT2-HHF2
Homologous recombination was used to replace the coding regions of the two endogenous H3 and H4 gene cassettes with vector and marker sequences. To disrupt HHT1-HHF1, DNA fragments flanking the H3-H4 coding region (corresponding to base pairs 1-212 and 1543-1800, where 615 denotes the A residue of the H3 initiator ATG codon) were created by PCR using genomic yeast DNA as the template. These fragments were cloned in tandem into the polylinker of a disruption vector, pRS405 (a gift from P.Heiter, Johns Hopkins University), carrying the LEU2 selectable marker. The resulting construct was linearized between two fragments and used to transform DY882 to Leu ϩ , and replacement of the entire HHT1-HHF1 coding region was confirmed by Southern analysis. The HHT2-HHF2 locus was replaced in a similar manner in DY881 (using PCR fragments corresponding to base pairs 35-367 and 1550-1760, where 747 denotes the A of the initiator ATG of HHT2), with pRS403 sequences carrying a HIS3 selectable marker. Again, His ϩ transformants were confirmed to have lost the HHT2-HHF2 coding regions by Southern analysis. Diploids produced by mating of these two mutant haploid strains were transformed with Ycp50-copy II (HHT2-HHF2) (generously provide by Dr M.A.Osley, Sloan Kettering), a plasmid bearing wild-type H3-H4-copy II alleles with their natural promoter and a URA3 selectable marker. This diploid was then sporulated and Ura ϩ , Leu ϩ , His ϩ haploid strains of both mating types were identified (WZY42 and WZY43) and confirmed to contain both of the above replacement alleles, so that the plasmid borne copy of HHT2-HHF2 is only source of histones H3 and H4 in these cells. Sequences of PCR primers used in these studies will be gladly provided upon request.
In vitro mutagenesis of HHT2-HHF2 cells A 1.8 kb SpeI fragment was isolated from Ycp50-copyII, blunted by treatment with Klenow DNA polymerase, and ligated to pRS414 centromeric vector sequences digested with SmaI and AflIII. The resulting vector, pWZ414-F12, carries the wild-type HHT2-HHF2 alleles with a TRP1 selectable marker. An AflII was added to this vector, generating pWZ414-F13, to aid in cloning the various mutant alleles described in Table III . Three different approaches were used to generate H3 and/or H4 mutant alleles: (i) oligonucleotides and a MORPH (5 prime-3 prime, Inc.) mutagenesis kit; (ii) overlap extension PCR strategies; or (iii) direct cloning of annealed, double-stranded oligonucleotides (as indicated). In addition to changing specific codons, closely linked (within a few base pairs) silent changes were also introduced to create restriction sites (as indicated) to aid in the identification of positive bacterial and yeast clones and to facilitate further cloning. To save space, oligonucleotide sequences are not listed here but will be gladly provided upon request. After cloning, the entire coding regions of all histone alleles were subjected to DNA sequencing before introduction into yeast to confirm the expected mutations and to ensure no other mutations had arisen during cloning procedures. a Overlap extension PCR was used to generate a fragment containing the indicated mutation and restriction sites, and the fragment was then cloned into the vector indicated. b All plasmids with an F number of 13 and above contain the AflII site introduced into pWZ414-F13. c The mutation (and/or restriction site) was introduced using the indicated oligonucleotide and the MORPH site-directed mutagenesis kit. d The indicated oligonucleotides were annealed and ligated directly into the appropriate vector. e Number of sites is indicated in parentheses.
Other plasmid constructions
To create a LYS2-marked GAL4-VP16 construct, a 2.8 kb ApaI-PvuII fragment from pPC97-VP16 413-470 was ligated to the ApaI-SmaI sites of pRS317. This plasmid was named pWZGP.
To create LYS2-marked integrating versions of the H3 Δ3-29, the H4 Δ4-19, and the combined H3 K14R, H4 K8,16R alleles (to confirm the synthetic lethality of these alleles upon segregation with gcn5 null alleles during sporulation), PvuI fragments containing these alleles were isolated from pWZ414-F14, pWZ414-F15 and pWZ414-F50, respectively, and ligated into PvuI-cut pRS404, yielding pWZ404-F14, pWZ404-F15 and pWZ404-F50. A PvuII fragment containing the LYS2 promoter and coding region was isolated from pMPK1 (a gift from M.Kladde, Pennsylvania State University) and ligated into the unique PvuII site of pWZ404-F14, pWZ404-F15 and pWZ404-F50.
Deletion of GCN5
GCN5 was deleted in WZY63 using a URA3 marked disruption vector as described previously (Marcus et al., 1994) to create WZY73 (URA ϩ ) (Table II) . After confirmation of GCN5 loss by Southern blot analysis, cells that had lost the URA3 marker were selected on 5-FOA-containing media (WZY76). The plasmid Ycp50-copyII was introduced into these cells, and the TRP1 marked pWZ414-F13 was lost after growth in Trp ϩ media. Trp-cells were identified by replica plating onto Trp ϩ and Trpmedia. Mutant histone alleles were then introduced into this strain (WZY81) by plasmid shuffle.
Plasmid shuffle of histone alleles
Mutant histone alleles on TRP1-marked plasmids (pWZ414 series) were introduced into GCN5 (WZY42) or gcn5 (WZY81) cells carrying wildtype histones on the URA3-marked Ycp50-copy II plasmid. After growth in Ura ϩ media, cells that had lost the URA3 plasmid were selected by growth on 5-FOA-containing media. Loss of the wild-type histone alleles and the presence of the mutant histone alleles were confirmed by Southern blot analysis.
β-Galactosidase assays β-Galactosidase assays were performed as described following transformation of strains listed in Table II with plasmid pWZGP (GAL4-
3165
VP16 413-470 construct from above) and plasmid pLGSD5 , which carries the β-galactosidase gene under the control of a single Gal4p binding site. Multiple colonies of each strain were assayed at least twice (more commonly three to five times), and the data presented are the averages of these multiple measurements.
Southern blotting
Genomic yeast DNA was isolated by a glass bead procedure as described previously (Rose et al., 1990) , digested with appropriate restriction enzymes and resolved by agarose electrophoresis. The DNA was then transferred from the gel to GENESCREENϩ membranes (NEN) by Posiblot (Stratagene). DNA blots were probed with randomly primed, 32 P-labeled probes, washed and exposed to X-ray film as described.
Topoisomer analysis
Total genomic yeast DNA prepared as described above (Rose et al., 1990) was resolved on 0.8% agarose gels containing 10 μg/ml chloroquine by electrophoresis at 75 V for 24 h. After transfer to a membrane as above, DNA was probed with sequences specific for the endogenous 2μ plasmid.
FACS analysis
Cells (15 ml) were grown to a density of 0.5-1ϫ10 7 cells/ml and harvested by centrifugation at 1000 g on a tabletop centrifuge. The cells were washed with one volume of phosphate-buffered saline (PBS), then resuspended in one volume (15 ml) of 70% ethanol and fixed at room temperature for 1 h with agitation. Cells were then rehydrated in PBS for 2 h at room temperature. Approximately 5ϫ10 6 cells were RNase treated in a volume of 0.5 ml of 200 mM Tris pH 8.0, 20 mM EDTA and 1 mg/ml RNase A overnight at 37°C. Cells were pelleted in a microfuge and resuspended in 0.1 ml of PBS and counted. Cells (1.5ϫ10 6 ) were then stained with 50 mM propidium iodide in a final volume of 0.1 ml of PBS for 2 h at room temperature in the dark. The cells were diluted with 400 μl of PBS, sonicated briefly and then counted on a Coulter EPICS XL-100 MCL flow-cytometer.
Histone preparation, acetyltransferase assays and Western blot analysis
Histones were isolated, resolved by SDS-PAGE and blotted to PVDF as described previously . Blots were blocked
